Cargando…

Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus

AIMS: Chronic kidney disease (CKD) and diabetes mellitus increase atherosclerotic cardiovascular diseases (ASCVD) risk. However, the association between renal outcome of diabetic kidney disease (DKD) and ASCVD risk is unclear. METHODS: This retrospective study enrolled 218 type 2 diabetic patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Honghong, Zhao, Lijun, Zou, Yutong, Wang, Yiting, Zhang, Junlin, Wu, Yucheng, Zhang, Rui, Wang, Tingli, Wang, Jiali, Zhu, Yitao, Guo, Ruikun, Xu, Huan, Li, Lin, Cooper, Mark E., Liu, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946063/ https://www.ncbi.nlm.nih.gov/pubmed/33685340 http://dx.doi.org/10.1080/0886022X.2021.1893186

Ejemplares similares

Whether Renal Pathology Is an Independent Predictor for End-Stage Renal Disease in Diabetic Kidney Disease Patients with Nephrotic Range Proteinuria: A Biopsy-Based Study
por: Wang, Tingli, et al.
Publicado: (2022)

Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease
por: Zou, Yutong, et al.
Publicado: (2022)

Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: a biopsy-based study
por: Wu, Yucheng, et al.
Publicado: (2021)

Association between serum uric acid and renal outcome in patients with biopsy-confirmed diabetic nephropathy
por: Zou, Yutong, et al.
Publicado: (2021)

Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
por: Zhao, Lijun, et al.
Publicado: (2020)

Clinical and Pathological Features of Chinese Patients with Type 2 Diabetes, Biopsy-Proven Diabetic Kidney Disease, and Rapid eGFR Decline
por: Qin, Chunmei, et al.
Publicado: (2022)

The association between the red cell distribution width and diabetic nephropathy in patients with type-2 diabetes mellitus
por: Zhang, Junlin, et al.
Publicado: (2018)

The association of plasma NT-proBNP level and progression of diabetic kidney disease
por: Zhao, Yuancheng, et al.
Publicado: (2023)

Implications of a Family History of Diabetes and Rapid eGFR Decline in Patients With Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Disease
por: Wang, Yiting, et al.
Publicado: (2019)

Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes
por: Zhao, Lijun, et al.
Publicado: (2021)

The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy
por: Zhang, Junlin, et al.
Publicado: (2019)

Association between serum alkaline phosphatase and renal outcome in patients with type 2 diabetes mellitus
por: Zhao, Lijun, et al.
Publicado: (2020)

FcgRIII Deficiency and FcgRIIb Defeciency Promote Renal Injury in Diabetic Mice
por: Zhang, Rui, et al.
Publicado: (2019)

Corrigendum to “FcgRIII Deficiency and FcgRIIb Defeciency Promote Renal Injury in Diabetic Mice”
por: Zhang, Rui, et al.
Publicado: (2020)

Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease
por: Wang, Yiting, et al.
Publicado: (2021)

Combining glomerular basement membrane and tubular basement membrane assessment improves the prediction of diabetic end‐stage renal disease
por: Zhao, Lijun, et al.
Publicado: (2021)

Addition of glomerular lesion severity improves the value of anemia status for the prediction of renal outcomes in Chinese patients with type 2 diabetes
por: Zhao, Lijun, et al.
Publicado: (2022)

Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy
por: Zhang, Junlin, et al.
Publicado: (2018)

Comparison of Performance of Equations for Estimated Glomerular Filtration Rate in Chinese Patients with Biopsy-Proven Diabetic Nephropathy
por: Wang, Yiting, et al.
Publicado: (2019)

Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease
por: Xiao, Xiang, et al.
Publicado: (2022)

Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes
por: Zhao, Lijun, et al.
Publicado: (2023)

TCM Regulates PI3K/Akt Signal Pathway to Intervene Atherosclerotic Cardiovascular Disease
por: Liu, Jiali, et al.
Publicado: (2021)

The gut microbiome in atherosclerotic cardiovascular disease
por: Jie, Zhuye, et al.
Publicado: (2017)

Endovascular Management of Atherosclerotic Renal Artery Stenosis: Post-Cardiovascular Outcomes in Renal Atherosclerotic Lesions Era Winner or False Alarm?
por: Karanikola, Evridiki, et al.
Publicado: (2017)

Cardiovascular magnetic resonance in carotid atherosclerotic disease
por: Dong, Li, et al.
Publicado: (2009)

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
por: Xiao, Xiang, et al.
Publicado: (2022)

Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) study
por: Chen, Tian, et al.
Publicado: (2019)

Percutaneous renal artery stent implantation in the treatment of atherosclerotic renal artery stenosis
por: Hu, Youbin, et al.
Publicado: (2018)

Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease
por: Fetterman, Jessica L., et al.
Publicado: (2016)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression
por: Zhang, Junlin, et al.
Publicado: (2022)

Inflammation in atherosclerotic cardiovascular disease
por: Shah, Prediman K., et al.
Publicado: (2019)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
por: Lin, Fang-Ju, et al.
Publicado: (2017)

Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis
por: Drummond, Christopher A., et al.
Publicado: (2017)

Association between 5-year change in cardiovascular risk and the incidence of atherosclerotic cardiovascular diseases: a multi-cohort study
por: Yi, Jiayi, et al.
Publicado: (2023)

Gycyrrhizic acid alleviates atherosclerotic lesions in rats with diabetes mellitus
por: Zhao, Yaodong, et al.
Publicado: (2021)

Association between renal function and platelet reactivity during aspirin therapy in elderly patients with atherosclerotic cardiovascular disease
por: Liang, Wenyi, et al.
Publicado: (2021)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Several circulating miRNAs related to hyperlipidemia and atherosclerotic cardiovascular diseases
por: Xu, Jiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lki0h5kk63qenme4i3aug58mdp